Prime Medicine, Inc. Common Stock (PRME) — Cash Flow Reinvestment Rate
Latest as of December 2024:
3.08x
Prime Medicine, Inc. Common Stock (PRME) has a Cash Flow Reinvestment Rate of 3.08x as of December 2024, reinvesting $50.04 Million (capex $1.79 Million plus investments $48.25 Million) from operating cash flow of $16.25 Million. Check PRME cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
3.08x
(Capex + Investments) / Operating CF
Total Reinvested
$50.04 Million
Capex + Investments
Operating Cash Flow
$16.25 Million
USD
Capital Expenditures
$1.79 Million
USD
Annual Cash Flow Reinvestment Rate for Prime Medicine, Inc. Common Stock (None–None)
Year-by-year capital reinvestment analysis for Prime Medicine, Inc. Common Stock. For live market cap and broader valuation context, see PRME stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow